The bactericidal drug targets are considered better targets for antitubercular drug 56 discovery both in terms of relapse of infection and countering drug resistance (12). The 57 compound 5g was evaluated for bactericidal activity against replicating aerobic and hypoxia-58 adapted dormant cultures of M. tuberculosis H37Rv. In the former, cells were grown to log 59 phase in Middlebrook 7H9 broth (Difco) followed by addition of the compound at 1x, 2x, 3x 60 and 4x MIC concentration. The cultures were incubated at 37 o C for 10 days without 61
2-enopyranosid-4-uloses was recently described by Saquib et al. (10, 11 ) as possessing very 51 good antitubercular activity. One of the compound 5g, on the basis of in vitro activity 52 against drug susceptible and MDR strains of M. tuberculosis was selected as lead 53 antitubercular compound (11). Compound 5g was further evaluated for bactericidal activity 54 against M. tuberculosis and in vivo activity in murine infection model (this study). 55
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shaking. Serial dilutions of cells were plated at 0 and 10 days on MB7H10 agar containing 62 OADC for CFU determination to determine the minimal bactericidal concentration (MBC) 63 that killed 99.9 % bacteria (12). MBC was found to be 3.125 mg/ L (4 x MIC) suggesting 64 an early bactericidal activity (Figure 1) . 65 Hypoxic cells were generated by growing the cells in uncoated vacutainer tubes without 66 shaking at 37ºC to allow self-generation of hypoxia in the cultures (13). Decolorization of 67
Methylene Blue was indicator of hypoxia. The drugs were added on day 28, after total 68 decolourization of methylene blue had occurred. Time of addition of 5g was taken as zero 69 time point. The hypoxic culture was incubated with compound 5g for 6 days. Isoniazid and 70
Metronidazole were taken as controls. At 3.125 mg/ L, 92.54 % inhibition while at 6.25, 71 95.32 % inhibition by 5g was observed (Table 1) . 72
The in-vivo efficacy of the selected compound 5g was evaluated in mouse model for acute 73 acacia and administered by oral gavage at doses of 10 and 25 mg/kg. Chemotherapy was 76 initiated 2 days later and continued for 30 days (6 days/ week). At the end of therapy, 6 mice 77 for each group were sacrificed, and 10-fold dilutions of lung homogenates were plated on 78 MB7H10-OADC agar for CFU determination.
Infected mice showed 1.28-1.44 log 10 79 reduction of the CFUs in lungs of infected mice treated with 10 and 25 mg/ kg dose of 80 compound 5g, compared to 2.8 log 10 reduction of the same by isoniazid which is indicative 81 of anti-TB activity (TAACF) ( Table 2 Having found a correlation between compound 5g and α-mannosidase, we evaluated other 102 compounds of the series for inhibition of alpha mannosidase. Three additional compounds 103
with Ki values ranging from 44.22 to 353.9 µM were identified from the series (10, Table  104 3). A structure activity relationship could be established as all four compounds inhibiting 105 alpha mannosidase activity had same substituent at C-6 (pivaloyl) and different alkyl 106 substituents at anomeric position (OMe, O t Butyl and O i amyl). Among three enulosides, 5a, 107 5g and 5e, 5a having a one carbon alkyl substituent (OMe) at the anomeric position exhibited 108 the best alpha mannosidase inhibitory activity. Increase in the number of carbon atoms in the 109 alkyl chain at the anomeric position led to a decrease in alpha mannosidase inhibitory 110 activity. Likewise replacement of pivaloyl (ester) substituent at C-6 position with a CN 111 substituent saw a dramatic increase in alpha mannosidase inhibitory activity as was observed 112 in the case of compound 13 ( Table 3 ). The fact that many molecules exhibiting alpha -113 mannosidase inhibitory activity have been found to possess anti-cancer as well as anti-viral 114 activity could use these molecules and SAR for designing of better and specific α-115 mannosidase inhibitors with anti-TB activity ( 16, 17, 18, 19) . 
